Better adherence to a transdermal tulobuterol patch than inhaled salmeterol in elderly chronic obstructive pulmonary disease patients
- 23 July 2012
- journal article
- research article
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 13 (2) , 398-404
Abstract
Background: Inhaled long‐acting β2‐agonists (LABA) are often poorly adhered to by elderly patients with chronic obstructive pulmonary disease (COPD). We hypothesized that older age and compromised cognitive function might contribute to poor adherence to inhaled medications among COPD patients, and that transdermally delivered medications could improve adherence, exercise tolerance and quality of life (QOL).Objective: To compare adherence and effects on health outcomes between transdermal and inhaled LABA.Methods: A total of 44 treatment‐naïve, elderly Japanese patients with moderate‐to‐severe COPD were treated with a transdermal tulobuterol patch (TP; 2 mg, once a day) or inhaled salmeterol (50 µg, twice a day) in a randomized crossover manner. The primary outcomes were adherence to the LABA medications and changes in QOL measured by the St George's Respiratory Questionnaire. Secondary outcomes were changes in 6‐min walk distance (6MWD) and spirometric values.Results: The overall adherence rate was 90.3 ± 1.6% for TP and 75.5 ± 2.9% for salmeterol (P < 0.001). Adherence to salmeterol was correlated with age and Mini‐Mental State Examination (MMSE) score (P < 0.05 and P < 0.01, respectively), although that to TP was relatively constant regardless of age and MMSE score. 6MWD and QOL were significantly improved from baseline after TP, but not after salmeterol treatment (P < 0.05). Similar degrees of increase in spirometric values occurred after treatment with TP and salmeterol.Conclusions: Adherence levels were higher overall with TP than with inhaled salmeterol, and more stable across age groups and MMSE levels. TP might be a favorable treatment option for COPD patients with poor adherence to an inhaled LABA. Geriatr Gerontol Int 2013; 13: 398–404.Keywords
This publication has 17 references indexed in Scilit:
- Effects of inhaled tiotropium plus transdermal tulobuterol versus tiotropium alone on impulse oscillation system (IOS)-assessed measures of peripheral airway resistance and reactance, lung function and quality of life in patients with COPD: A randomized crossover studyPulmonary Pharmacology & Therapeutics, 2011
- COPD in the Elderly PatientSeminars in Respiratory and Critical Care Medicine, 2010
- Adherence to controller therapy for chronic obstructive pulmonary disease: a reviewCurrent Medical Research and Opinion, 2010
- Once-Daily Bronchodilators for Chronic Obstructive Pulmonary Disease: Indacaterol Versus TiotropiumAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Additive effects of transdermal tulobuterol to inhaled tiotropium in patients with COPDRespiratory Medicine, 2010
- COMPARISON OF ADHERENCE AND EFFICACY BETWEEN INHALED SALMETEROL AND TRANSDERMAL TULOBUTEROL PATCH IN ELDERLY PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISORDERJournal of the American Geriatrics Society, 2009
- Adherence to treatment by patients with asthma or COPD: Comparison between inhaled drugs and transdermal patchRespiratory Medicine, 2007
- Quality of Life Changes in COPD Patients Treated With SalmeterolAmerican Journal of Respiratory and Critical Care Medicine, 1997
- The pharmacokinetics of the ?2-adrenoceptor agonist, tulobuterol, given transdermally and by inhalationEuropean Journal of Clinical Pharmacology, 1993
- “Mini-mental state”Journal of Psychiatric Research, 1975